Search Results - Rajesha Rupaimoole
- Showing 1 - 20 results of 45
- Go to Next Page
-
1
MicroRNA therapeutics: principles, expectations, and challenges by Rajesha Rupaimoole, Hee‐Dong Han, Gabriel López-Berestein, Anil K. Sood
Published 2011Editorial -
2
-
3
-
4
-
5
Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p by Elena G. Seviour, Vishal Sehgal, Dhruva K. Mishra, Rajesha Rupaimoole, Cristian Rodriguez‐Aguayo, Gabriel López-Berestein, J. S. Lee, Anil K. Sood, M P Kim, Gordon B. Mills, Prahlad T. Ram
Published 2016Artigo -
6
Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer by Qianghua Hu, Takeshi Hisamatsu, Monika Haemmerle, Min Soon Cho, Sunila Pradeep, Rajesha Rupaimoole, Cristian Rodriguez‐Aguayo, Gabriel López-Berestein, Stephen T.C. Wong, Anil K. Sood, Vahid Afshar‐Kharghan
Published 2017Artigo -
7
Personalized RNA Medicine for Pancreatic Cancer by Maud-Emmanuelle Gilles, Liangliang Hao, Ling Huang, Rajesha Rupaimoole, Pedro P. López‐Casas, Emilia M. Pulver, Jong Cheol Jeong, Senthil K. Muthuswamy, Manuel Hidalgo, Sangeeta N. Bhatia, Frank J. Slack
Published 2018Artigo -
8
Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis by Hemant Joshi, Indira V. Subramanian, Erica Schnettler, Goutam Ghosh, Rajesha Rupaimoole, Colleen Evans, Manju Saluja, Yawu Jing, Cristina Ivan, Sabita Roy, Yan Zeng, Vijay H. Shah, Anil K. Sood, Sundaram Ramakrishnan
Published 2014Artigo -
9
<scp>MiR</scp>‐506 inhibits multiple targets in the epithelial‐to‐mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer by Yan Sun, Limei Hu, Hong Zheng, Marina Bagnoli, Yuhong Guo, Rajesha Rupaimoole, Cristian Rodriguez‐Aguayo, Gabriel López-Berestein, Ping Ji, Kexin Chen, Anil K. Sood, Delia Mezzanzanica, Jinsong Liu, Baocun Sun, Wei Zhang
Published 2014Artigo -
10
Role of Focal Adhesion Kinase in Regulating YB–1–Mediated Paclitaxel Resistance in Ovarian Cancer by Yu Kang, Wei Hu, Cristina Ivan, Heather J. Dalton, Takahito Miyake, Chad V. Pecot, Behrouz Zand, Tao Liu, Jie Huang, Nicholas B. Jennings, Rajesha Rupaimoole, Morgan Taylor, Sunila Pradeep, Sherry Y. Wu, Chunhua Lü, Yunfei Wen, Jianfei Huang, Jinsong Liu, Anil K. Sood
Published 2013Artigo -
11
Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers by Guoyan Liu, Da Yang, Rajesha Rupaimoole, Chad V. Pecot, Yan Sun, Lingegowda S. Mangala, Xia Li, Ping Ji, David Cogdell, Limei Hu, Yingmei Wang, Cristian Rodriguez‐Aguayo, Gabriel López-Berestein, Ilya Shmulevich, Loris De Cecco, Kexin Chen, Delia Mezzanzanica, Fengxia Xue, Anil K. Sood, Wei Zhang
Published 2015Artigo -
12
Molecular Biomarkers of Residual Disease after Surgical Debulking of High-Grade Serous Ovarian Cancer by Susan L. Tucker, Kshipra M. Gharpure, Shelley M. Herbrich, Anna K. Unruh, Alpa M. Nick, Erin K. Crane, Robert L. Coleman, Jamie Guenthoer, Heather J. Dalton, Sherry Y. Wu, Rajesha Rupaimoole, Gabriel López-Berestein, Bülent Özpolat, Cristina Ivan, Wei Hu, Keith Baggerly, Anil K. Sood
Published 2014Artigo -
13
Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth by Jie Huang, Wei Hu, Limin Hu, Rebecca A. Previs, Heather J. Dalton, Xiao-yun Yang, Yunjie Sun, Michael H. McGuire, Rajesha Rupaimoole, Archana S. Nagaraja, Yu Kang, Tao Liu, Alpa M. Nick, Nicholas B. Jennings, Robert L. Coleman, Robert B. Jaffe, Anil K. Sood
Published 2016Artigo -
14
Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer by Da Yang, Yan Sun, Limei Hu, Hong Zheng, Ping Ji, Chad V. Pecot, Yanrui Zhao, Sheila M. Reynolds, Hanyin Cheng, Rajesha Rupaimoole, David Cogdell, Matti Nykter, Russell R. Broaddus, Cristian Rodriguez‐Aguayo, Gabriel López-Berestein, Jinsong Liu, Ilya Shmulevich, Anil K. Sood, Kexin Chen, Wei Zhang
Published 2013Artigo -
15
Autocrine Effects of Tumor-Derived Complement by Min Soon Cho, Hernan G. Vasquez, Rajesha Rupaimoole, Sunila Pradeep, Sherry Y. Wu, Behrouz Zand, Hee‐Dong Han, Cristian Rodriguez‐Aguayo, Justin Bottsford-Miller, Jie Huang, Takahito Miyake, Hyun Jin Choi, Heather J. Dalton, Cristina Ivan, Keith Baggerly, Gabriel López-Berestein, Anil K. Sood, Vahid Afshar‐Kharghan
Published 2014Artigo -
16
Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer by Yu Kang, Archana S. Nagaraja, Guillermo N. Armaiz-Peña, Piotr L. Dorniak, Wei Hu, Rajesha Rupaimoole, Tao Liu, Kshipra M. Gharpure, Rebecca A. Previs, Jean M. Hansen, Cristian Rodriguez‐Aguayo, Cristina Ivan, Prahlad T. Ram, Vasudha Sehgal, Gabriel López-Berestein, Susan K. Lutgendorf, Steve W. Cole, Anil K. Sood
Published 2015Artigo -
17
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER by Twan van den Beucken, Elizabeth Koch, Kenneth C. Chu, Rajesha Rupaimoole, Peggy Prickaerts, Michiel Adriaens, Jan Willem Voncken, Adrian L. Harris, Francesca M. Buffa, Syed Haider, Maud H. W. Starmans, Cindy Q. Yao, Mircea Ivan, Cristina Ivan, Chad V. Pecot, Paul C. Boutros, Anil K. Sood, Marianne Koritzinsky, Bradly G. Wouters
Published 2014Artigo -
18
A new method for stranded whole transcriptome RNA-seq by David F. Miller, Pearlly S. Yan, Aaron Buechlein, Blanca Rodríguez, Ayse Selen Yilmaz, Shokhi Goel, Hai Lin, Bridgette M. Collins‐Burow, Lyndsay V. Rhodes, Chris Braun, Sunila Pradeep, Rajesha Rupaimoole, Mehmet Dalkılıç, Anil K. Sood, Matthew E. Burow, Haixu Tang, Tim H.‐M. Huang, Yunlong Liu, Douglas B. Rusch, Kenneth P. Nephew
Published 2013Artigo -
19
Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression by Rajesha Rupaimoole, Cristina Ivan, Da Yang, Kshipra M. Gharpure, Sherry Y. Wu, Chad V. Pecot, Rebecca A. Previs, Archana S. Nagaraja, Guillermo N. Armaiz-Peña, Michael H. McGuire, Sunila Pradeep, L S Mangala, Cristian Rodriguez‐Aguayo, Leaf Huang, Menashe Bar‐Eli, W Zhang, Gabriel López-Berestein, George A. Călin, Anil K. Sood
Published 2016Artigo -
20
XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A by Takahito Miyake, Sunila Pradeep, Sherry Y. Wu, Rajesha Rupaimoole, Behrouz Zand, Yunfei Wen, Kshipra M. Gharpure, Archana S. Nagaraja, Wei Hu, Min Soon Cho, Heather J. Dalton, Rebecca A. Previs, Morgan Taylor, Takeshi Hisamatsu, Yu Kang, Tao Liu, Sharon Shacham, Dilara McCauley, David H. Hawke, John E. Wiktorowicz, Robert L. Coleman, Anil K. Sood
Published 2015Artigo
Search Tools:
Related Subjects
Biology
Cancer research
Cancer
Gene
Medicine
Internal medicine
Genetics
Ovarian cancer
Biochemistry
Cell biology
Metastasis
microRNA
Gene silencing
Downregulation and upregulation
Endocrinology
Immunology
Oncology
Cancer cell
Chemistry
Chemotherapy
RNA
Signal transduction
RNA interference
Receptor
Angiogenesis
Apoptosis
Cell
Computational biology
Pathology
Pharmacology